DRDO 2-DG drug could be game-changer against COVID: Karnataka Health Minister Ruchika Sharma16 May 2021 9:15 AM ISTBengaluru: The 2-DG drug developed by the Defence Research and Development Organisation (DRDO) could be a game-changer in the fight against COVID,...
Bharat Biotech gets DCGI nod for Phase 2,3 Covaxin trials on 2 to 18 years Ruchika Sharma14 May 2021 3:02 PM ISTNew Delhi: The Drugs Controller General of India (DCGI) on Thursday approved Phase 2 and 3 clinical trial of Bharat Biotech's COVAXIN vaccine in the...
Zydus Cadila single dose COVID drug Virafin priced at Rs 11,995 per dose Medical Dialogues Team12 May 2021 5:18 PM ISTNew Delhi: Zydus Cadila's price fixation of its single-dose COVID drug Virafin at Rs 11,995 per dose claiming that it can cut oxygen dependency in...
Glenmark FabiFlu knocks out top-selling Zincovit with April sales of Rs 352 crore Medical Dialogues Team11 May 2021 6:40 PM ISTMumbai: Knocking out top-selling multivitamin brand Zincovit, Glenmark Pharmaceutical's Covid-19 drug Favipiravir, marketed as FabiFlu secured the...
DRDO anti-COVID drug gets DCGI emergency use nod Ruchika Sharma10 May 2021 12:04 PM ISTThe 2-DG comes in powder form in sachet and is taken orally by dissolving it in water.
Bajaj Healthcare launches COVID drug favipiravir under brand name Favijaj in India Ruchika Sharma5 May 2021 11:50 AM ISTNew Delhi: Drug firm Bajaj Healthcare on Tuesday announced the launch of its antiviral Favipiravir tablets under the brand name ''Favijaj'' used for...
Biocon partners with Karnataka pharma firm to produce Remdesivir Medical Dialogues Team5 May 2021 9:30 AM ISTBelgavi: In response to the rapid rise in demand for the antiviral drug Remdesivir in COVID care hospitals, taking a significant step towards meeting...
VINS Bioproducts bags DCGI nod to begin VINCOV-19 trials Ruchika Sharma27 April 2021 1:22 PM ISTHyderabad: VINS Bioproducts on Monday received approval from the Drugs Controller General of India (DCGI) to commence the clinical trials for...
Optimus Pharma Anti-Parkinson's drug Safinamide gets DCGI okay Ruchika Sharma27 April 2021 12:10 PM ISTHyderabad: Optimus Pharma has announced that it has received DCGI approval for its Anti-Parkinson's drug Safinamide. Safinamide is indicated as...
COVID Vaccination in India- Developments and Controversies Medical Dialogues Team26 April 2021 8:08 PM ISTNew Delhi: Engulfed by a calamitous coronavirus wave, the Government rolled out anti-COVID vaccines for the immunization programme against the deadly...
Bharat Biotech seeks DCGI nod for extension of Covaxin shelf life from 6 to 24 months Ruchika Sharma26 April 2021 12:48 PM ISTNew Delhi: Bharat Biotech has written to India's drug regulator seeking extension of the shelf-life of its indigenously developed Covid-19 vaccine...
Zydus Cadila gets DCGI nod to moderate Covid-19 drug Virafin Ruchika Sharma24 April 2021 1:06 PM ISTVirafin will be available on the prescription of medical specialist for use in hospital/ institutional setup.
